Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
This page is not indexed by search engines while we improve data quality.
Furet Pascal patents
Furet Pascal holds 30 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 30 |
| Recent patents | 0 |
| First publication | Jan 22, 2015 |
| Latest publication | Jan 29, 2019 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
US-2018134695-A1 · May 17, 2018 · US
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
US-9896449-B2 · Feb 20, 2018 · US
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
US-9896444-B2 · Feb 20, 2018 · US
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
US-9802917-B2 · Oct 31, 2017 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
US-2018134695-A1 · May 17, 2018 · US
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
US-9896449-B2 · Feb 20, 2018 · US
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
US-9896444-B2 · Feb 20, 2018 · US
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
US-9802917-B2 · Oct 31, 2017 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 30 |
| Chemistry & Metallurgy | 30 |
| Cross-Sectional Technologies | 2 |